Overcoming the Tower of Babel in Medical Science by Finding the “EQUATOR”: Research Reporting Guidelines

Academic Emergency Medicine

Volumn 24, Issue 8, 2017, Pages 1030-1033

  Carpenter, Christopher R ^a   Meisel, Zachary F ^b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DISEASE SEVERITY; EMERGENCY MEDICINE; EMERGENCY WARD; HUMAN; MEDICAL LITERATURE; MEDICINE; NOTE; PRACTICE GUIDELINE; PRIORITY JOURNAL; THORAX PAIN;

EID: 85020504841     PISSN: 10696563     EISSN: 15532712     Source Type: Journal    
DOI: 10.1111/acem.13225     Document Type: Note

References (40)

1. Seager SB. Cardiac enzymes in the evaluation of chest pain. Ann Emerg Med 1980;9:346–9.
2. Kohn MA, Carpenter CR, Newman TB. Understanding the direction of bias in studies of diagnostic test accuracy. Acad Emerg Med 2013;20:1194–206.
3. Simel DL, Feussner JR, DeLong ER, Matchar DB. Intermediate, indeterminate, and uninterpretable diagnostic test results. Med Decis Mak 1987;7:107–14.
4. Mulherin SA, Miller WC. Spectrum bias or spectrum effect? Subgroup variation in diagnostic test evaluation. Ann Intern Med 2002;137:598–602.
5. Hayden SR, Brown MD. Likelihood ratio: a powerful tool for incorporating the results of a diagnostic test into clinical decision making. Ann Emerg Med 1999;33:575–80.
6. Brown MD, Reeves MJ. Evidence-based emergency medicine skills for evidence-based emergency care. Interval likelihood ratios: another advantage for the evidence-based diagnostician. Ann Emerg Med 2003;42:292–7.
7. Bastian H, Glasziou P, Chalmers I. Seventy-five trials and eleven systematic reviews a day: how will we ever keep up? PLoS Med 2010;7:e1000326.
8. Docherty M, Smith R. The case for structuring the discussion of scientific papers. BMJ 1999;318:1224–5.
9. Morris AH, Ioannidis JP. Limitations of medical research and evidence at the patient-clinician encounter scale. Chest 2013;143:1127–35.
10. Moher D, Simera I, Schulz KF, Hoey J, Altman DG. Helping editors, peer reviewers and authors improve the clarity, completeness and transparency of reporting health research. BMC Med 2008;6:13.
11. Ioannidis JP, Greenland S, Hlatky MA, et al. Increasing value and reducing waste in research design, conduct, and analysis. Lancet 2014;383:166–75.
12. Begg C, Cho M, Eastwood S, et al. Improving the quality of reporting of randomized controlled trials. The CONSORT Statement. JAMA 1996;276:637–9.
13. Schulz KF, Altman DG, Moher D. CONSORT 2010 Statement: updated guidelines for reporting parallel group randomised trials. BMC Med 2010;8:18.
14. Moher D, Schulz KF, Simera I, Altman DG. Guidance for developers of health research reporting guidelines. PLoS Med 2010;7:e1000217.
15. Altman DG, Simera I. A history of the evolution of guidelines for reporting medical research: the long road to the EQUATOR Network. J R Soc Med 2016;109:67–77.
16. Bossuyt PM, Reitsma JB, Bruns DE, et al. STARD 2015: an updated list of essential items for reporting diagnostic accuracy studies. BMJ 2015;351:h5528.
17. Collins GS, Reitsma JB, Altman DG, Moons KG. Transparent reporting of a multivariable prediction model for individual prognosis or diagnosis (TRIPOD): the TRIPOD statement. BMJ 2015;350:g7594.
18. Moher D, Liberati A, Tetzlaff J, Altman DG. Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement. Ann Intern Med 2009;151:264–9.
19. Pinnock H, Barwick M, Carpenter CR, et al. Standards for Reporting Implementation Studies (StaRI) Statement. BMJ 2017;356:i6795.
20. Ogrinc G, Davies L, Goodman D, Batalden P, Davidoff F, Stevens D. SQUIRE 2.0 (Standards for QUality Improvement Reporting Excellence): Revised publication guidelines from a detailed consensus process. BMJ Qual Saf 2016;25:986–92.
21. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vanderbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Ann Intern Med 2007;147:573–7.
22. Tong A, Flemming K, McInnes E, Oliver S, Craig J. Enhancing transparency in reporting the synthesis of qualitative research: ENTREQ. BMC Med Res Methodol 2012;12:181.
23. Gagnier JJ, Kienle G, Altman DG, Moher D, Sox H, Riley D. The CARE guidelines: consensus-based clinical case report guideline development. J Clin Epidemiol 2014;67:46–51.
24. Korevaar DA, Wang J, van Enst WA, et al. Reporting diagnostic accuracy studies: some improvements after 10 years of STARD. Radiology 2015;274:781–9.
25. Korevaar DA, Cohen JF, Hooft L, Bossuyt PM. Literature survey of high-impact journals revealed reporting weaknesses in abstracts of diagnostic accuracy studies. J Clin Epidemiol 2015;686:708–15.
26. Gallo L, Hua N, Mercuri M, Silveira A, Worster A. Adherence to standards for reporting diagnostic accuracy in emergency medicine research. Acad Emerg Med 2017;24:914–919.
27. Kanzaria HK, McCabe AM, Meisel ZM, et al. Advancing patient-centered outcomes in emergency diagnostic imaging: a research agenda. Acad Emerg Med 2015;22:1435–46.
28. El Dib R, Tikkinen KA, Akl EA, et al. Systematic survey of randomized trials evaluating the impact of alternative diagnostic strategies on patient-important outcomes. J Clin Epidemiol 2017;84:61–69.
29. To MJ, Jones J, Emara M, Jadad AR. Are reports of randomized controlled trials improving over time? A systematic review of 284 articles published in high-impact general and specialized medical journals. PLoS Med 2013;8:e84779.
30. Stevens A, Shamseer L, Weinstein E, et al. Relation of completeness of reporting of health research to journals’ endorsement of reporting guidelines: systematic review. BMJ 2014;348:g3804.
31. Tao KM, Li XQ, Zhou QH, Moher D, Ling CQ, Yu WF. From QUOROM to PRISMA: a survey of high-impact medical journals’ instructions to authors and a review of systematic reviews in anesthesia literature. PLoS One 2011;6:e27611.
32. Hirst A, Altman DG. Are peer reviewers encouraged to use reporting guidelines? A survey of 116 health research journals. PLoS Med 2012;7:e35621.
33. Fleming PS, Koletsi D, Pandis N. Blinded by PRISMA: are systematic reviewers focusing on PRISMA and ignoring other guidelines? PLoS Med 2014;9:e96407.
34. Campbell MK, Elbourne DR, Altman DG. CONSORT statement: extension to cluster randomised trials. BMJ 2004;328:702–8.
35. Ioannidis JP, Evans SJ, Gotzsche PC, et al. Better reporting of harms in randomized trials: an extension of the CONSORT statement. Ann Intern Med 2004;14:781–8.
36. Piaggio G, Elbourne DR, Altman DG, Pocock SJ, Evans SJ. Reporting of noninferiority and equivalence randomized trials: an extension of the CONSORT statement. JAMA 2006;295:1152–60.
37. Zwarenstein M, Treweek S, Gagnier JJ, et al. Improving the reporting of pragmatic trials: an extension of the CONSORT statement. BMJ 2008;337:a2390.
38. Boutron I, Moher D, Altman DG, Schulz KF, Ravaud P. Methods and processes of the CONSORT Group: example of an extension for trials assessing nonpharmacologic treatments. Ann Intern Med 2008;148:W60–6.
39. Welch V, Petticrew M, Tugwell P, et al. PRISMA-Equity 2012 extension: reporting guidelines for systematic reviews with a focus on health equity. PLoS Med 2012;9:e1001333.
40. Simel DL, Rennie D, Bossuyt PM. The STARD statement for reporting diagnostic accuracy studies: application to the history and physical examination. J Gen Intern Med 2008;23:768–74.